Reply: The REAC-TAVI Trial: Better Antiplatelet Therapy, Less Haze on the Horizon

JACC Cardiovasc Interv. 2019 Apr 22;12(8):803-804. doi: 10.1016/j.jcin.2019.02.038.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aortic Valve Stenosis / surgery*
  • Blood Platelets
  • Humans
  • Platelet Aggregation Inhibitors
  • Transcatheter Aortic Valve Replacement*
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors